Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Umbilical Cord Blood Transplantation
Early-onset thyrotoxicosis occurs after cord blood transplant in acute myelogenous leukemia
August 14th, 2006
Early-onset thyrotoxicosis occurs after unrelated umbilical cord blood transplantation in acute myelogenous leukemia. According to recent research from Japan, "Thyroid dysfunction is a common complication after allogeneic hematopoietic stem cell transplantation (SCT). However, thyrotoxicosis as defined by elevated serum-free thyroxine (FT,) or free triiodothyronine (FT,) levels together with low thyroid-stimulating hormone (TSH) levels is rare after SCT. "Here we describe 2 patients who developed thyrotoxicosis within the first 50 days after unrelated cord blood transplantation (CBT)," wrote T. Konuma and colleagues at the University of Tokyo. ...
Source: Stem Cell Week (2006-08-14)
|
